FeesSafety
Pluang+

Senseonics and Beta Bionics launch integrated Eversense 365 CGM with iLet Bionic Pancreas for easier diabetes management

Market News
16 Nov 2026, 23:13 WIB
GlobeNewsWire
View Source
Bullish
Senseonics and Beta Bionics launch integrated Eversense 365 CGM with iLet Bionic Pancreas for easier diabetes management

Senseonics and Beta Bionics have commercially launched the integration of the Eversense 365 continuous glucose monitoring (CGM) system with the iLet Bionic Pancreas. This combination offers a year-long accurate glucose sensor paired with an automated insulin delivery system that adapts to individual needs, reducing the daily burden of diabetes management. The launch fulfills their Q4 2026 timeline and expands treatment options for people with diabetes. Future plans include integrating Eversense 365 with Beta Bionics' Mint tubeless patch pump to further enhance insulin delivery choices.

Senseonics and Beta Bionics integration news is presented with Pluang's health sector data for context. As of Nov 17, 2026 03:31 WIB, 31 of 150 health stocks rose while 118 fell. Notable movers include ARWR at USD 44.78 with a -6.28% change, SANA at USD 1.90 with -6.19% and 100% buy order activity, and MESO at USD 12.47 with -6.03%.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
2 hours ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
2 hours ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
3 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
4 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App